Question 1

What percentage of BCAX is owned by institutions?

Accepted Answer

Based on Q1 2026 13F filings, institutional ownership of Bicara Therapeutics Inc. Common Stock stands at 103.6%, held across 145 reporting institutions.

Question 2

Who is the largest institutional holder of BCAX?

Accepted Answer

RA CAPITAL MANAGEMENT, L.P. is the largest reported institutional holder of BCAX, with approximately 7,255,993 shares worth $0.14B as of Q1 2026.

Question 3

Is BCAX a hedge fund favorite?

Accepted Answer

Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of BCAX, including CITADEL ADVISORS LLC.

Question 4

What is BCAX's Smart Money Score?

Accepted Answer

Our composite Smart Money Score for BCAX is 61 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

Question 5

How many institutions bought BCAX this quarter?

Accepted Answer

32 institutions opened new positions in BCAX during Q1 2026, while 25 fully exited. 99 added to existing positions and 14 trimmed.

Question 6

How is institutional ownership of BCAX changing?

Accepted Answer

BCAX institutional ownership rose by 29.96 percentage points quarter-over-quarter, with a net change of +7 holders.

Question 7

How concentrated is BCAX ownership among the top holders?

Accepted Answer

The top 10 institutions account for 64.0% of all reported 13F value in BCAX, and the top 25 account for 88.8%.

Question 8

Where does this BCAX institutional ownership data come from?

Accepted Answer

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.

#	Institution	Shares Held	Market Value	QoQ Change	Ownership %	% of Fund
1	RA CAPITAL MANAGEMENT, L.P.	7.3M	$144.3M	+4.3%	13.246%	1.53%
2	Siren, L.L.C.	5.8M	$115.4M	+11.2%	10.593%	3.20%
3	Vestal Point Capital, LP	5.4M	$107.9M	+51.7%	9.903%	3.02%
4	Deep Track Capital, LP	4.1M	$80.8M	+55.4%	7.416%	1.67%
5	JANUS HENDERSON GROUP PLC	3.3M	$66.1M	+25.7%	6.073%	0.03%
6	Red Tree Management, LLC	3.2M	$63.1M	0.0%	5.788%	56.39%
7	TPG GP A, LLC	3.0M	$59.9M	0.0%	5.495%	1.63%
8	BlackRock, Inc.	2.8M	$56.6M	+12.5%	5.191%	0.00%
9	Omega Fund Management, LLC	2.4M	$47.6M	+8.5%	4.367%	29.16%
10	Royalty Pharma Sub-Manager, LLC	2.4M	$46.7M	—	4.360%	13.57%
11	FMR LLC	2.1M	$41.8M	-37.2%	3.835%	0.00%
12	VANGUARD CAPITAL MANAGEMENT LLC	1.8M	$35.3M	—	3.239%	0.00%
13	CITADEL ADVISORS LLC	1.7M	$34.3M	+116.6%	3.151%	0.02%
14	FRANKLIN RESOURCES INC	1.6M	$32.3M	+0.1%	2.960%	0.01%
15	STATE STREET CORP	1.4M	$28.2M	-14.0%	2.591%	0.00%
16	Jones Hill Capital LP	1.3M	$25.1M	—	2.300%	5.37%
17	GEODE CAPITAL MANAGEMENT, LLC	831K	$16.5M	+2.4%	1.517%	0.00%
18	FIL Ltd	680K	$13.5M	-10.4%	1.241%	0.01%
19	ORBIMED ADVISORS LLC	667K	$13.3M	+219.1%	1.218%	0.28%
20	ACORN CAPITAL ADVISORS, LLC	643K	$12.8M	0.0%	1.175%	3.64%
21	Aisling Capital Management LP	569K	$11.3M	0.0%	1.039%	2.38%
22	GOLDMAN SACHS GROUP INC	559K	$11.1M	+1.2%	1.020%	0.00%
23	Palo Alto Investors LP	550K	$10.9M	+84.3%	1.005%	1.67%
24	Rock Springs Capital Management LP	489K	$9.7M	+14.0%	0.893%	0.57%
25	NAN FUNG TRINITY (HK) Ltd	428K	$8.5M	+14.9%	0.781%	0.93%

Quarter	Inst. Holders	Δ Holders	Ownership %	Δ Ownership	Total 13F Value	Δ Value
Q1 2026	145	+5.1%	103.60%	+29.96 pp	$1.23B	+41%
Q4 2025	138	+23%	73.64%	+10.17 pp	$875M	+16%
Q3 2025	112	+5.7%	63.47%	+25.21 pp	$754M	+66%
Q2 2025	106	+13%	38.26%	13.05 pp	$455M	25%
Q1 2025	94	+12%	51.31%	14.84 pp	$610M	22%
Q4 2024	84	+22%	66.15%	8.38 pp	$786M	11%
Q3 2024	69	—	74.53%	—	$886M	—

Bicara Therapeutics Inc. Common Stock (BCAX) Institutional Ownership

AI Insights & Key Takeaways

Top Institutional Holders of BCAX

Quarterly Institutional Activity

BCAX Institutional Ownership by Quarter

BCAX — Frequently Asked Questions